ORA - Oxford University Research Archive

1 - 18 of 18

1

Journal article

Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance

Nash, P, Mease, PJ, Fleishaker, D, et al.
2020-11-16

2

Journal article

Safety and efficacy of Tofacitnib in patients with active psoriatic arthritis: Interim analysis of OPAL balance, an open-label, long-term extension study

Nash, P, Coates, LC, Kivitz, AJ, et al.
2020-06-06

3

Journal article

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study

Coates, L, Nash, P, Kvien, TK, et al.
2020-05-15

4

Journal article

Ageism, Healthy Life Expectancy and Population Ageing: How Are They Related?

Officer, A, Thiyagarajan, JA, Schneiders, ML, et al.
2020-05-01

5

Journal article

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study

Coates, LC, Gladman, DD, Nash, P, et al.
2018-12-07

6

Journal article

Efficacy of tofacitinib for the treatment of psoriatic arthritis: pooled analysis of two phase 3 studies

Nash, P, Coates, LC, Fleischmann, R, et al.
2018-11-09

7

Journal article

Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease

Helliwell, P, Coates, LC, Fitzgerald, O, et al.
2018-10-29

8

Conference item

Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, up to 36 Months in Patients with Active Psoriatic Arthritis: Data from the Third Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study

Nash, P, Coates, LC, Kivitz, AJ, et al.
2018-10-15

9

Conference item

Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis

Conference abstract
Helliwell, P, Coates, LC, Fitzgerald, O, et al.
2018-06-12

10

Conference item

Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of opal balance, an open-label, long-term extension study

conference abstract
Nash, P, Coates, LC, Kivitz, AJ, et al.
2018-06-12

11

Journal article

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology consensus‐based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis

Coates, LC, FitzGerald, O, Merola, JF, et al.
2017-11-26

12

Journal article

Remission in psoriatic arthritis—where are we now?

Coates, LC, Conaghan, PG, D'Agostino, MA, et al.
2017-10-16

13

Journal article

Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol.

Goldsmith, PM, Bottomley, MJ, Okechukwu, O, et al.
2017-07-17

14

Journal article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Smolen, JS, Landewé, R, Bijlsma, J, et al.
2017-03-06

15

Journal article

Valuing older people: time for a global campaign to combat ageism

Officer, A, Schneiders, ML, Wu, D, et al.
2016-10-01

16

Conference

Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate

Reginster, J-Y, Chapurlat, R, Berenbaum, F, et al.
2013-10-05

17

Conference

STRONTIUM RANELATE PREVENTS RADIOLOGICAL PROGRESSION IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS: A RESPONDERS ANALYSIS

Cooper, C, Berenbaum, F, Nash, P, et al.
2013-04-05

18

Journal article

Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study

Nash, P, Coates, LC, Fleishaker, D, et al.

TO TOP